• 제목/요약/키워드: Healthcare costs

검색결과 190건 처리시간 0.019초

문재인 정부의 건강보험 보장성 강화대책 (Moon Jae-in Government's Plan for Benefit Expansion in National Health Insurance)

  • 박은철
    • 보건행정학회지
    • /
    • 제27권3호
    • /
    • pp.191-198
    • /
    • 2017
  • Moon Jae-in Government announced the Government's 5-Year Plan on July 19, 2017, President Moon directly announced the Government's Plan for Benefit Expansion in National Health Insurance on August 7, 2017. The main contents of the announced expansion include benefit coverage for all medically necessary services with control over non-covered service occurrence, a decrease in the cost-sharing upper limit, and monetary support for catastrophic medical costs. Although past governments have been continuously striving for benefit expansion in the last 15 years, this plan has its breakthrough aspect in that all medical services will be covered by the National Health Insurance. In alignment, there are important tasks to solve: attaining a proper fee schedule, reforming the healthcare delivery system, and improving healthcare quality. This plan is a symptom oriented action in that it is limited in reducing patients' out-of-pocket money, unlike the systematic approach of the National Health Insurance. The sustainability of the National Health Insurance is being threatened due to South Korea's low birth rate, rapidly aging society, and low economic growth, in addition to the unification issue of the Korean Peninsula, medical utilization of the elderly, management of non-communicable diseases, and so on. Therefore, the Government needs to plan the National Health Insurance system reformation including actions addressed toward medical consumers.

RFID를 이용한 검체 프린팅 시스템 (Clinical Specimen Printing System using RFID)

  • 김용필;최광일;정회경
    • 한국정보통신학회논문지
    • /
    • 제18권2호
    • /
    • pp.351-356
    • /
    • 2014
  • 최근 들어 검체 관리의 부실 및 병리 정보의 불일치 등으로 의료사고가 증가하고 있다. 또한, 향후 불치병 치료와 신약 개발의 결과 검증을 위해 많은 병기 조직의 수요가 예측되며, 환자의 병력, 투약 정보, 검사결과에 따른 맞춤형 의료용 병기 관리가 필요한 실정이다. 본 논문에서는 RFID를 기반하여 U-Healthcare 환경을 지원할 수 있는 바이오 병리조직 통합 프린팅 시스템을 제안하였다. 바이오 병리조직의 검사, 관리 시스템 지원을 통해 효율적 업무와 비용 절감 기대되며, 무엇보다도 의료사고를 원천적으로 방지할 수 있는 시스템으로 활용될 것이다.

A Study on the Regional Gap Analysis and Management of the Elderly Health in an Aging Society

  • YOO, Chae-Hyun;SHIN, Seung-Jung
    • International journal of advanced smart convergence
    • /
    • 제10권2호
    • /
    • pp.168-174
    • /
    • 2021
  • Korea is ranked as the world's No. 1 country in its aging rate. While the interest and demand for health is rapidly increasing, the health status of the elderly is in the lowest among OECD members. Increased chronic diseases, the burden of medical costs and digital/untact changes of societies after COVID-19 have caused the direction of healthcare to be changed from treatment oriented to health care and prevention oriented, along with increased income levels and a desire for a healthy life. Amid this paradigm of change, the gap in health standards and health inequality for the elderly according to local structure and social conditions affects not only socio-economic but also the quality of life for individual senior citizen. Utilizing prior data of Aging Research Panel Survey, this study aims to compare and analyze health conditions and regional gaps which are significant influences on the satisfaction of the life of the elderly, and to suggest direction of studies for health care to provide solutions for health inequalities. The findings are intended to be a basic data for researching models of the New Normal Smart Healthcare System that bridge the health gap between the elderly and enhance life satisfaction with health care models suitable for regional characteristics in aging society.

신노년세대의 시니어 주거에 대한 선호조사와 미래 방향 고찰 (Surveying the preferences of new generation of seniors for retirement housing and exploring future directions)

  • 권순정;박화옥;임정원;윤극한
    • 의료ㆍ복지 건축 : 한국의료복지건축학회 논문집
    • /
    • 제29권4호
    • /
    • pp.21-28
    • /
    • 2023
  • Purpose: This study is to analyze the preferences for future senior housing that reflects the characteristics of the new generation of seniors and to consider the direction of future senior housing. Methods: Data from an online survey of a new generation of older adults and group interviews with professionals and baby boomers were analyzed. The data collected from the survey and interview have been using quantitative analysed method. Literature surveys also have been carried out. Results: The results show that future senior housing requires a change in perception through conceptual expansion from the Aging in Place (AIP) to the Aging in Community (AIC) paradigm. The preferences of the new generation of seniors for future senior housing were examined to determine their preferences for location, facility size and type, unit floor plans and services, and living costs. Implications: The direction of senior housing services and architectual plans for seniors aged 55 to 65 years old were discussed.

미국의 CHES 프로그램: 현대 보건교육사의 역할과 제도의 발전 (The United States CHES Program: The Role and Development of the Modern Health Educator)

  • Sohn, Ae-Ree;Burzo, Jamie
    • 보건교육건강증진학회지
    • /
    • 제27권5호
    • /
    • pp.63-71
    • /
    • 2010
  • 목적: 보건교육 분야는 상대적으로 새로운 영역이나 전 세계적으로 건강증진의 중요성에 대한 요구가 강조되면서 빠르게 발전되고 있다. 많은 나라에서 보건교육사 프로그램을 제도화하는 노력을 하고 있다. 본 연구는 미국의 보건교육사 제도를 고찰함으로써 국제적 보건교육사 제도의 개발 및 발전에 기여하는 데 있다. 방법: 본 연구는 문헌고찰을 통하여 미국의 자격증 제도, 보건교육사의 역사 및 다양한 현장에서 보건교육사의 역할과 특성을 파악하였다. 결과: 보건교육사의 역할과 기술은 현장에 따라 다르게 요구되나 크게 일곱 가지의 대영역으로 분류되며, 35개의 기술 분야에서 163개의 하위기술이 필요한 것으로 나타났다. 미국은 의료비의 증가로 인하여 만성질환의 조기발견과 예방사업을 위하여 미국의 보건교육사는 2006년에 2006명에서 2016년에는 78,000명으로 증가될 것으로 전망된다. 보건교육사는 다양한 분야에서 고용되고 있으며, 주로 지역사회 건강단체, 연구소, 보건센터(병원, 의원, 보건소), 학교, 정부공무원 및 사업체 등에서 활동하고 있다. 결론: 미국의 보건교육사 제도의 발전은 보건교육사 프로그램을 개발하고 발전시키고자 하는 여러 나라에 좋은 모델이 될 수 있다. 또한 미국 보건교육사의 다양성과 전문성은 한국의 보건교육사 제도의 발전에 도움이 될 것으로 여겨진다.

위험분담제도에 대한 고찰: 항암제 사례를 중심으로 (Overview of Risk-Sharing Schemes: Focusing on Anticancer Drugs)

  • 손현순;신현택
    • 한국임상약학회지
    • /
    • 제23권2호
    • /
    • pp.89-96
    • /
    • 2013
  • This article aimed to introduce 'risk sharing' schemes for pharmaceuticals between drug manufacturers and healthcare payer. Published literature review was undertaken to summarize risk sharing concepts and collect information on existing scheme examples in other countries focusing on new anticancer drugs. Risk sharing schemes could be categorized into health outcomes-based and non-outcomes (financial) based ones. Outcome-based schemes could be broken down into performance-linked reimbursement and conditional coverage. Performance-linked reimbursement can be further broken into outcomes guarantee and pattern or process of care and conditional coverage included coverage with evidence development and conditional treatment continuation schemes. Non-outcome based schemes included market share and price volume at population level, and utilization caps and manufacturer funded treatment initiation at patient level. We reviewed the fifteen examples for anticancer drugs that risk sharing agreements in response to the inherent uncertainties and increased costs of eleven anticancer drugs. Of them, eight cases were coverage with evidence development schemes. The anticancer drugs except bevacizumab and cetuximab were all listed on the national health insurance formulary in Korea, with reimbursement criteria defined on the basis of approved indications and administrations. Risk sharing approach may be a useful tool to ensure values for drug expenditure, but there are a number of concerns such as high administration costs, lack of transparency and conflicts of interest, especially for performance-based health outcomes reimbursement schemes.

설사형 과민성 장 증후군 남성 환자에게 사용되는 ramosetron 의 경제성 평가 (Economic Evaluation of Ramosetron in Male Patients with Diarrhea-predominant Irritable Bowel Syndrome in Korea)

  • 손현순;이태진;김선
    • 한국임상약학회지
    • /
    • 제20권3호
    • /
    • pp.268-277
    • /
    • 2010
  • This study was conducted to analyze the cost-utility of ramosetron monotherapy, trimebutine monotherapy and trimebutine+loperamide combination therapy in male diarrhea-predominant patients with irritable bowel syndrome (IBS) in Korean healthcare setting. We constructed a decision-analytical model to estimate both total costs for each state of health and outcomes such as IBS-symptoms improvement for 3 and 6 months time horizon. Base analysis found that for ramosetron treatment with the price of KW910 for 5 ${\mu}g$ tablet, incremental cost effectiveness ratios (ICERs, cost per quality-adjusted life day) were KW85,000 and KW62,000 for 3 months and 6 months, respectively, compared with trimebutine. But ramosetron was a dominant strategy when compared with trimebutine+loperamide for both 3 months and 6 months. Sensitivity analyses showed robust results for drug acquisition costs till ramosetron price of KW950/tablet. In conclusion, ramosetron was a cost-effective regimen compared with trimebutine or trimebutine+loperamide from the societal perspective.

Continuity of Care in Chronic Diseases: A Concept Analysis by Literature Review

  • Hu, Jingjing;Wang, Yuexia;Li, Xiaoxi
    • 대한간호학회지
    • /
    • 제50권4호
    • /
    • pp.513-522
    • /
    • 2020
  • Purpose: This study aimed to utilize concept analysis to obtain a better understanding of the concept of "continuity of care" in chronic diseases. Methods: The concept of continuity of care was analyzed using the Walker and Avant method. Covering literature in English from 1930 to 2018, the data sources included CINAHL Complete, Academic Search Complete, MEDLINE, PsyARTICLES, Health Source: Nursing/Academic Edition, Google Scholar, Science Direct, and the Cochrane Library. Results: A comprehensive definition of concept of continuity of care was developed based on a systematic search and synthesis. The key defining attributes were identified as (a) care over time, (b) the relationship between an individual patient and a care team, (c) information transfer, (d) coordination, and (e) meeting changing needs. The antecedents of continuity of care were having a chronic disease, inexperienced with disease management, a poorly coordinated healthcare system, and medical care limitations. The consequences of continuity of care were decreasing hospital admissions, reducing costs, reducing emergency room visits, improving the quality of life, improving patient satisfaction, and delivering good healthcare. Conclusion: The thorough concept analysis provides insight into the nature of "continuity of care" in chronic diseases and also helps ground the concept in healthcare.

지방공사의료원과 의료법인의 성과 비교 (A Comparison Study of Performance between Local Government Hospitals and General Hospitals)

  • 김상미;황성완;윤서중;강정규
    • 디지털융복합연구
    • /
    • 제11권11호
    • /
    • pp.463-470
    • /
    • 2013
  • 이 논문은 지방공사의료원과 의료법인 간의 성과에 영향을 미치는 요인을 분석하여 지방공사의료원의 효율적인 경영을 재무적으로 파악하는데 있다. 연구자료는 국세청 공익법인 공시시스템에 공시되어 있는 67개 의료기관의 재무성과를 조사하였다. 병원 현황 및 의료기기 정보는 2012년 2분기 건강보험심사평가원의 자료와 대한병원협회 명부를 사용하였다. 일반적 특성으로 지방공사의료원은 의료법인보다 시나 군 지역에 많이 분포하였고, 간호등급 4등급 이하가 대부분을 차지하고 있었다. 지방공사의료원과 의료법인 간 의료이익, 당기순이익을 분석한 결과 지방공사 의료원이 의료법인에 비해서 적자병원이 많은 것으로 파악되었다. 대부분의 지방공사의료원이 의료이익, 당기순이익에서 적자를 보이고 있어, 수익성을 악화시키는 요인들을 개선할 필요가 있으며, 지금과 같이 의료법인과 경쟁관계를 지양하고, 필수공익의료를 제공하는 조직으로 병원구조를 변화시키도록 노력해야 할 것이다.

Systems Biology and Emerging Technologies Will Catalyze the Transition from Reactive Medicine to Predictive, Personalized, Preventive and Participatory (P4) Medicine

  • Galas, David J.;Hood, Leroy
    • Interdisciplinary Bio Central
    • /
    • 제1권2호
    • /
    • pp.6.1-6.4
    • /
    • 2009
  • We stand at the brink of a fundamental change in how medicine will be practiced. Over the next 5-20 years medicine will move from being largely reactive to being predictive, personalized, preventive and participatory (P4). Technology and new scientific strategies have always been the drivers of revolutions and this is certainly the case for P4 medicine, where a systems approach to disease, new and emerging technologies and powerful computational tools will open new windows for the investigation of disease. Systems approaches are driving the emergence of fascinating new technologies that will permit billions of measurements on each individual patient. The challenge for health information technology will be how to reduce this enormous amount of data to simple hypotheses about health and disease. We predict that emerging technologies, together with the systems approaches to diagnosis, therapy and prevention will lead to a down turn in the escalating costs of healthcare. In time we will be able to export P4 medicine to the developing world and it will become the foundation of global medicine. The "democratization" of healthcare will come from P4 medicine. Its first real emergence will require the unprecedented integration of biology, medicine, technology and computation. as well as societal issues of major importance: ethical, regulatory, public policy, economic, and others. In order to effectively move the P4 scientific agenda forward new strategic partnerships are now being created with the large-scale integration of complementary skills, technologies, computational tools, patient records and samples and analysis of societal issues. It is evident that the business plans of every sector of the healthcare industry will need to be entirely transformed over the next 10 years.and the extent to which this will be done by existing companies as opposed to newly created companies is a fascinating question.